The Plk1 inhibitor BI 2536 in patients with refractory or...

The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study

Vose, Julie M., Friedberg, Jonathan W., Waller, Edmund K., Cheson, Bruce D., Juvvigunta, Vasthala, Fritsch, Holger, Petit, Claude, Munzert, Gerd, Younes, Anas
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
54
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2012.729833
Date:
April, 2013
File:
PDF, 266 KB
english, 2013
Conversion to is in progress
Conversion to is failed